Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDA Chemotherapy and Auto-HSCT for Stage IV ENKTL
NCT02764281Completed
- Sponsor
- Xinhua Hospital
- Start
- Apr 2015
- Primary completion
- Feb 2020
- Modality
- Therapeutic Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate, etoposide, dexamethasone and pegaspargase in Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT), sponsored by Xinhua Hospital. Primary endpoint: Complete Response Rate. Started Apr 2015; status: completed.
02
Drugs
methotrexateetoposidedexamethasonepegaspargase
03
Conditions
Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT)
Beyond the preview
Go deeper on NCT02764281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02764281.